RA CAPITAL MANAGEMENT L.P. - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, 6, ...28, 29, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-15
4:49 pm
Purchase
2025-03-3113GAvalo Therapeutics, Inc.
AVTX
RA CAPITAL MANAGEMENT L.P.1,094,407
9.900%
127,108increase
(+13.14%)
Filing
History
2025-05-15
4:49 pm
Sale
2025-03-3113GVerona Pharma plc
VRNA
RA CAPITAL MANAGEMENT L.P.6,011,112
7.100%
-1,766,830decrease
(-22.72%)
Filing
History
2025-05-15
4:48 pm
Sale
2025-03-3113GAdagio Medical Holdings, Inc.
ADGM
RA CAPITAL MANAGEMENT L.P.1,200,000
7.200%
-413,220decrease
(-25.61%)
Filing
History
2025-05-14
6:34 pm
Purchase
2025-05-1213DiTeos Therapeutics, Inc.
ITOS
RA CAPITAL MANAGEMENT L.P.4,163,276
9.900%
504,230increase
(+13.78%)
Filing
History
2025-05-14
6:09 pm
Purchase
2025-05-1213DWerewolf Therapeutics, Inc.
HOWL
RA CAPITAL MANAGEMENT L.P.6,746,807
15.000%
553,926increase
(+8.94%)
Filing
History
2025-05-09
4:19 pm
Purchase
2025-05-0713DLENZ Therapeutics, Inc.
LENZ
RA CAPITAL MANAGEMENT L.P.4,260,606
15.100%
4,260,606increase
(New Position)
Filing
History
2025-04-30
4:51 pm
Purchase
2025-04-2813DJade Biosciences, Inc.
JBIO
RA CAPITAL MANAGEMENT L.P.1,324,954
4.100%
1,324,954increase
(New Position)
Filing
History
2025-04-04
4:32 pm
Purchase
2025-03-2813GSutro Biopharma, Inc.
STRO
RA CAPITAL MANAGEMENT L.P.4,434,637
5.300%
4,434,637increase
(New Position)
Filing
History
2025-03-31
4:57 pm
Purchase
2025-03-2713DAcumen Pharmaceuticals, Inc.
ABOS
RA CAPITAL MANAGEMENT L.P.15,016,063
24.800%
34,445increase
(+0.23%)
Filing
History
2025-03-31
4:54 pm
Purchase
2025-03-2713DTyra Biosciences, Inc.
TYRA
RA CAPITAL MANAGEMENT L.P.10,684,890
20.100%
7,750increase
(+0.07%)
Filing
History
2025-03-17
7:58 pm
Purchase
2025-03-1313DMineralys Therapeutics, Inc.
MLYS
RA CAPITAL MANAGEMENT L.P.6,287,597
9.900%
1,338,290increase
(+27.04%)
Filing
History
2025-03-10
4:33 pm
Purchase
2025-03-0613DJanux Therapeutics, Inc.
JANX
RA CAPITAL MANAGEMENT L.P.11,971,377
19.900%
1,528,196increase
(+14.63%)
Filing
History
2025-03-03
8:17 pm
Unchanged
2025-02-2713D89bio, Inc.
ETNB
RA CAPITAL MANAGEMENT L.P.20,013,733
13.700%
0
(Unchanged)
Filing
History
2025-02-21
4:15 pm
Purchase
2025-02-1913DSolid Biosciences Inc.
SLDB
RA CAPITAL MANAGEMENT L.P.7,989,820
9.900%
3,631,342increase
(+83.32%)
Filing
History
2025-02-18
4:25 pm
Purchase
2025-02-1013DSionna Therapeutics, Inc.
SION
RA CAPITAL MANAGEMENT L.P.10,445,322
23.700%
10,445,322increase
(New Position)
Filing
History
2025-02-14
6:43 pm
Sale
2024-12-3113GVerona Pharma plc
VRNA
RA CAPITAL MANAGEMENT L.P.7,777,942
8.900%
-682,148decrease
(-8.06%)
Filing
History
2025-02-14
6:43 pm
Purchase
2024-12-3113GUnicycive Therapeutics, Inc.
UNCY
RA CAPITAL MANAGEMENT L.P.1,152,012
9.900%
104,775increase
(+10.00%)
Filing
History
2025-02-14
6:42 pm
Sale
2024-12-3113GTenaya Therapeutics, Inc.
TNYA
RA CAPITAL MANAGEMENT L.P.0
0.000%
-7,980,736decrease
(Position Closed)
Filing
History
2025-02-14
6:42 pm
Purchase
2024-12-3113GNewAmsterdam Pharma Company N.V.
NAMS
RA CAPITAL MANAGEMENT L.P.10,875,454
9.900%
1,779,865increase
(+19.57%)
Filing
History
2025-02-14
6:41 pm
Sale
2024-12-3113GRecursion Pharmaceuticals, Inc.
RXRX
RA CAPITAL MANAGEMENT L.P.7,725,096
2.000%
-7,659,519decrease
(-49.79%)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5, 6, ...28, 29, Next